Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.17 USD | -7.08% | +20.89% | +278.54% |
Jun. 07 | COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says | RE |
Jun. 06 | S&P 500, Nasdaq dip on the eve of US payrolls data | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+278.54% | 2.55B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- FDA Authorizes Novavax COVID Shot as Mix-and-Match Booster to Pfizer or Moderna: CNBC